Clinical Trials
Eisai: Updated Analysis of Phase Ib/II Study of Eribulin and Pembrolizumab Combination Regimen
Eisai Co .Ltd. announced that a presentation on the updated analysis of a global Phase Ib/II clinical study (ENHANCE 1 / Study 218) of...
Press Releases
Sartorius Stedim Biotech Launches New Versions of Data Analytics Software Solutions
Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry, has introduced a new version of its SIMCA® and SIMCA®-online data analytical...
Packaging & Labelling
WestRock’s Multi Packaging Solutions is ‘Talking Packs’
Multi Packaging Solutions, (MPS), a business of WestRock Company and a leader in value-added print and packaging solutions for the healthcare, branded consumer and...
News
Agendia and UZ Leuven Partner to Co-Validate MammaPrint® BluePrint® Breast Cancer Risk of Recurrence and Molecular Subtyping Kit Ahead of European Launch
Agendia, a world leader in personalized medicine and molecular cancer diagnostics, and University Hospitals Leuven (UZ Leuven) in Belgium have partnered to co-validate Agendia’s...
Articles
Influenza Is Nothing to Sneeze At
The Zika virus is considered a major global health risk, as infection during pregnancy is associated with babies born with microcephaly. ...
Press Releases
ADC Bio signs construction agreement with sector specialists WHP
ADC Biotechnology – a specialist ADC contract services company with proprietary conjugation technology designed to overcome process and aggregation challenges during the development of...
Press Releases
CluePoints Responds to Sponsor and CRO Demand with Two New Appointments
CluePoints, a leading provider of Risk-Based Monitoring (RBM) and Data Quality Oversight solutions for clinical trials, has announced two new strategic appointments to strengthen...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read